Aveanna Healthcare Holdings Inc. (AVAH) saw its stock price soar 5.06% during Monday's intraday session.

The significant upward movement follows a key analyst rating upgrade. Raymond James raised its rating on Aveanna Healthcare to "strong buy" from "outperform," providing a positive catalyst for investor sentiment. Separately, analysis from RBC Capital Markets suggested a recent post-earnings sell-off was "overdone," noting the company's fundamentals remain strong despite investor concerns over private duty nursing rate updates.

RBC's note highlighted that Aveanna is well-positioned with a growing preferred payer network expected to drive volume-led revenue growth. The brokerage also pointed out that management's 2026 guidance does not include the potential contribution from the planned acquisition of Family First Homecare.